Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal


           Year.

Effective as of January 27, 2022, the Board of Directors (the "Board") of Omega Healthcare Investors, Inc. ("Omega" or the "Company") adopted an amendment and restatement of the Company's Amended and Restated Bylaws (as so amended and restated, the "Bylaws"). The Bylaws were amended and restated to, among other things, provide for voting "for" and "against" director nominees, set forth provisions regarding the conduct of stockholder meetings, and provide procedures for meetings of the Board during the existence of emergency conditions.

The foregoing description of the Bylaws is not complete and is qualified in its entirety by reference to the full text of the Bylaws, as amended and restated, a copy of which is attached hereto as Exhibit 3.1 and incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On January 27, 2022, the Company issued a press release announcing that its Board approved a stock repurchase program authorizing Omega to purchase up to $500 million of its common stock, par value $0.10 per share, from time to time through March 31, 2025.

Stock may be repurchased in open market or in privately negotiated transactions, and the amount and timing of any repurchases, will be dependent on various factors, including market conditions and corporate and regulatory considerations. Omega intends to finance any stock repurchases through cash flow from operations, balance sheet cash, planned asset sales, and/or borrowings under Omega's revolving credit facility.

The information furnished in Exhibit 99.1, shall not be deemed "filed" for any purpose, including for the purposes of the Exchange Act, or otherwise subject to the liabilities of that Section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits






 (d) Exhibits

Exhibit No. Description of Exhibit






    3.1      Amended and Restated Bylaws of Omega Healthcare Investors, Inc., as
           of January 27, 2022
    99.1     Press Release dated January 27, 2022
  104      Cover Page Interactive Data File (embedded within the Inline XBRL
           document)

© Edgar Online, source Glimpses